DuPont de Nemours (DD) Aperçu de l'action
DuPont de Nemours, Inc. fournit des matériaux et des solutions technologiques aux États-Unis, au Canada, en Asie-Pacifique, en Amérique latine, en Europe, au Moyen-Orient et en Afrique. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 3/6 |
| Croissance future | 3/6 |
| Performances passées | 2/6 |
| Santé financière | 6/6 |
| Dividendes | 2/6 |
Récompenses
Analyse des risques
DD Community Fair Values
Create NarrativeSee what 55 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
DuPont de Nemours, Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$47.15 |
| Plus haut sur 52 semaines | US$83.40 |
| Plus bas sur 52 semaines | US$33.34 |
| Bêta | 1.06 |
| Variation sur 1 mois | 0.94% |
| Variation sur 3 mois | -6.47% |
| Variation sur 1 an | -30.67% |
| Variation sur 3 ans | -29.13% |
| Variation sur 5 ans | -44.35% |
| Évolution depuis l'introduction en bourse | 384.97% |
Nouvelles et mises à jour récentes
Mise à jour du récit • May 07
DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside
Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.Seeking Alpha • May 07
DuPont: Margin Momentum Is Real, And The Market Is Starting To Take Notice (Rating Downgrade)
Summary DuPont de Nemours has repositioned its portfolio, driving strong Q1 results and a 28% share rally over six months. Management raised full-year guidance, now expecting $2.35–$2.40 EPS and $7.16–$7.22B sales, citing segment strength and new product launches. Despite robust execution and shareholder returns, DD's forward P/E of ~21x and recent rally leave shares fairly valued with limited near-term upside. I downgrade DD from buy to hold, noting Middle East risks to Water segment and the need to monitor segment performance for downside. Read the full article on Seeking AlphaRecent updates
Mise à jour du récit • May 07
DD: PFAS Legal Overhang Will Set Up Future Buyback And Guidance Upside
Analysts have slightly adjusted their 12 month price target for DuPont de Nemours to about $63.81 from $64.00. This reflects updated assumptions for revenue growth, profit margins and future P/E expectations.Seeking Alpha • May 07
DuPont: Margin Momentum Is Real, And The Market Is Starting To Take Notice (Rating Downgrade)
Summary DuPont de Nemours has repositioned its portfolio, driving strong Q1 results and a 28% share rally over six months. Management raised full-year guidance, now expecting $2.35–$2.40 EPS and $7.16–$7.22B sales, citing segment strength and new product launches. Despite robust execution and shareholder returns, DD's forward P/E of ~21x and recent rally leave shares fairly valued with limited near-term upside. I downgrade DD from buy to hold, noting Middle East risks to Water segment and the need to monitor segment performance for downside. Read the full article on Seeking AlphaMise à jour du récit • Apr 23
DD: PFAS Legal Overhang Will Set Up Future Water And Healthcare Upside
Analysts reaffirm a $64.00 price target on DuPont de Nemours, citing modest adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in their overall view of the shares. What's in the News DuPont plans to seek shareholder approval in May 2026 for a potential reverse stock split of its common stock at a ratio between 1 for 2 and 1 for 4, with the board retaining discretion on timing and whether to proceed.
Mise à jour du récit • Apr 08
DD: Share Actions And Water Solutions Expansion Will Shape A Measured Outlook
Analysts have adjusted the price target for DuPont de Nemours from $44 to $50, reflecting updated assumptions around revenue growth, profit margins, a revised discount rate, and slightly lower future P/E expectations. What's in the News DuPont plans to seek shareholder approval to amend its certificate of incorporation to allow a reverse stock split of common shares at a ratio between 1-for-2 and 1-for-4, with the exact ratio and timing at the discretion of the board.Mise à jour du récit • Mar 24
DD: PFAS Legal Overhang Will Set Up Future Product Expansion Upside
Analysts have raised their price target on DuPont de Nemours from about $55 to $64, citing updated assumptions for revenue growth, profit margins, and a lower discount rate that together support a reduced future P/E estimate. What's in the News The company plans to seek shareholder approval for a reverse stock split in a range of 1 for 2 to 1 for 4 at the May 21, 2026 annual meeting.
Mise à jour du récit • Mar 09
DD: Water Technology Expansion And 2026 Guidance Will Support Future Upside
Analysts have kept their $56.13 price target for DuPont de Nemours unchanged, citing largely steady assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E. Together, these factors signal a consistent outlook on the stock's risk and return profile.Mise à jour du récit • Feb 23
DD: New Guidance And Product Pipeline Will Support Future Upside
Analysts have raised their price target on DuPont de Nemours from about $49.19 to $56.13, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E that they view as better reflecting the company’s potential risk and return profile. What's in the News Issued new earnings guidance for the first quarter of 2026, with expected net sales of $1,670 million.Article d’analyse • Feb 17
There May Be Reason For Hope In DuPont de Nemours' (NYSE:DD) Disappointing Earnings
The market was pleased with the recent earnings report from DuPont de Nemours, Inc. ( NYSE:DD ), despite the profit...Mise à jour du récit • Feb 09
DD: Legal PFAS Overhang Will Set Up Future Product Expansion Upside
Analysts have revised their price target for DuPont de Nemours from about US$113 to roughly US$55, reflecting updated views on fair value, a higher discount rate, softer revenue growth expectations, slightly lower profit margins, and a higher assumed future P/E multiple. What's in the News DuPont launched the FilmTec MXP RO-8038-FF reverse osmosis element for dairy processors, designed as a drop in option for mesh wrapped systems that targets around 5% higher active membrane area and up to 50% higher productivity compared with conventional mesh wrapped elements, while aiming to reduce wastewater and maintain existing plant setups (Product related announcement).Mise à jour du récit • Jan 26
DD: Share Buybacks Will Drive Future Upside As New Plant Expands Capacity
Analysts have raised their price target for DuPont de Nemours from US$47.31 to US$49.19, citing updated assumptions around discount rates, revenue trends, profit margins and a revised future P/E outlook. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit related to alleged PFAS risks in firefighter turnout gear that names DuPont alongside other manufacturers, allowing claims under multiple legal theories, including RICO, to proceed for now (Lawsuits & Legal Issues).Mise à jour du récit • Jan 12
DD: Share Returns And Qnity Separation Will Frame A Measured Forward Outlook
Analysts have maintained their price target for DuPont de Nemours at $44.00, with this reaffirmed view supported by updated assumptions of a smaller revenue decline, higher profit margins, and a lower future P/E multiple. What's in the News A Montana federal judge denied motions to dismiss a class-action lawsuit alleging DuPont and other manufacturers concealed health risks linked to PFAS chemicals in firefighter turnout gear, allowing RICO and other claims to proceed for now (Lawsuits & Legal Issues).Mise à jour du récit • Dec 27
DD: Share Buybacks Will Drive Future Upside As New China Plant Expands Capacity
Narrative Update on DuPont de Nemours Analysts have modestly raised their average price target on DuPont de Nemours by approximately $0.06, reflecting slightly improved views on the company’s discount rate and profit margin outlook, despite marginally weaker revenue growth expectations. What's in the News Begins construction of a new MOLYKOTE specialty lubricants plant in Zhangjiagang, China, expanding global capacity and targeting fast growing demand across transportation, industrial, energy, and electronics markets, with operations expected to start in early 2027 (Key Developments) The board authorizes a share repurchase program of up to $2 billion, indicating a focus on capital returns to shareholders (Key Developments) Issues updated 2025 guidance, trimming full year net sales expectations to $6.84 billion and guiding fourth quarter net sales of about $1.685 billion (Key Developments) Declares a quarterly dividend of $0.20 per share, payable December 15, 2025, and also approves a pro rata special dividend to spin off Qnity to existing shareholders on November 1, 2025 (Key Developments) Introduces new safety and industrial products, including Tyvek APX high breathability chemical protective garments and IntegraTec XTP 100 IG ultrafiltration modules, together with new comfort and mobility testing protocols for soft ballistic body armor (Key Developments) Valuation Changes Fair Value: risen slightly from $47.25 to about $47.31 per share, indicating a marginally higher intrinsic value estimate.Mise à jour du récit • Dec 13
DD: Share Returns And Qnity Separation Will Shape A Balanced Outlook
Narrative Update Analysts have cut their average 12 month price target on DuPont de Nemours to approximately 44 dollars from about 62 dollars. This reflects reduced expectations for revenue growth and profit margins, along with a higher assumed valuation multiple and discount rate.Mise à jour du récit • Nov 29
DD: Share Repurchase Plan Will Drive Upside as New Plant Breaks Ground
Analysts have revised their price target for DuPont de Nemours downward by $6.00 to $47.25, citing recent adjustments in growth and profitability expectations. What's in the News DuPont broke ground on a new MOLYKOTE specialty lubricants manufacturing plant in Zhangjiagang, China.Mise à jour du récit • Nov 15
DD: Future Share Buybacks Will Unlock Value Amid Uncertainty
Analysts have revised their price target for DuPont de Nemours sharply downward from $93.69 to $53.25, citing updated financial forecasts and increased market uncertainty. What's in the News DuPont unveiled Tyvek APX, a new disposable chemical garment fabric designed for increased comfort and breathability without compromising protection.Article d’analyse • Nov 09
DuPont de Nemours (NYSE:DD) Is Paying Out Less In Dividends Than Last Year
DuPont de Nemours, Inc. ( NYSE:DD ) is reducing its dividend from last year's comparable payment to $0.20 on the 15th...Mise à jour du récit • Nov 01
DD: Qnity Separation And Water Solutions Will Drive Outperformance
Analysts have slightly reduced their price target for DuPont de Nemours from $93.81 to $93.69. This change reflects modest adjustments in growth forecasts and profitability expectations.Mise à jour du récit • Oct 17
Electronics, Healthcare And Water Will Drive Future Success
Analysts have raised their price target for DuPont de Nemours from $92.67 to $93.81. They cite modest improvements in profit margin expectations and slightly adjusted growth assumptions as the reasons for this change.Mise à jour du récit • Sep 24
Electronics, Healthcare And Water Will Drive Future Success
Despite a reduced revenue growth outlook, improved net profit margins have driven the consensus analyst price target for DuPont de Nemours up from $89.31 to $92.67. What's in the News DuPont is actively pursuing strategic bolt-on acquisitions, focusing on enhancing capabilities and targeting growth opportunities, while maintaining a balanced approach between buybacks and M&A.Mise à jour du récit • Sep 04
Electronics, Healthcare And Water Will Drive Future Success
As DuPont de Nemours’ revenue growth and discount rate forecasts remained steady, analysts kept their price target unchanged at $89.31. What's in the News Analyst/Investor Day announced.Article d’analyse • Jul 23
Is DuPont de Nemours, Inc. (NYSE:DD) Trading At A 47% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, DuPont de Nemours fair value estimate is US$146 DuPont de...Seeking Alpha • Apr 07
DuPont: Upgrading To Hold Amid China Risks
Summary DuPont shares have underperformed the broader market since my Sell recommendation was published. A new antitrust probe by the Chinese government is a negative but the stock's valuation reflects this risk. I believe it will be difficult for the company to meet consensus EPS estimates given the macroeconomic backdrop. I up upgrading the stock to Hold as a view the risk-reward more balanced for the stock now than was previously the case. Read the full article on Seeking AlphaRendement pour les actionnaires
| DD | US Chemicals | US Marché | |
|---|---|---|---|
| 7D | -6.8% | -3.2% | -0.3% |
| 1Y | -30.7% | 7.8% | 26.7% |
Rendement vs Industrie: DD a sous-performé le secteur US Chemicals qui a rapporté 7.8 % au cours de l'année écoulée.
Rendement vs marché: DD a sous-performé le marché US qui a rapporté 26.7 % au cours de l'année écoulée.
Volatilité des prix
| DD volatility | |
|---|---|
| DD Average Weekly Movement | 4.9% |
| Chemicals Industry Average Movement | 7.4% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: DD n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché US.
Volatilité au fil du temps: La volatilité hebdomadaire de DD ( 5% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 2015 | 15,000 | Lori Koch | www.dupont.com |
DuPont de Nemours, Inc. fournit des matériaux et des solutions technologiques aux États-Unis, au Canada, en Asie-Pacifique, en Amérique latine, en Europe, au Moyen-Orient et en Afrique. Elle opère à travers deux segments, Healthcare & Water Technologies et Diversified Industrials. La société propose des composants spécialisés pour les appareils médicaux, les emballages et les vêtements, ainsi que des combinaisons de protection sous la marque TYVEK ; elle fournit des solutions de filtration et de séparation de l'eau, notamment des éléments, des modules et des systèmes destinés principalement aux marchés des eaux usées industrielles et de l'énergie, aux applications municipales et de dessalement, ainsi qu'aux secteurs des sciences de la vie et aux secteurs spécialisés.
DuPont de Nemours, Inc. Résumé des fondamentaux
| DD statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$19.37b |
| Bénéfices(TTM) | US$132.00m |
| Recettes(TTM) | US$6.92b |
146.4x
Ratio P/E2.8x
Ratio P/SLe site DD est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| DD compte de résultat (TTM) | |
|---|---|
| Recettes | US$6.92b |
| Coût des recettes | US$4.50b |
| Marge brute | US$2.42b |
| Autres dépenses | US$2.29b |
| Les revenus | US$132.00m |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 0.32 |
| Marge brute | 35.01% |
| Marge bénéficiaire nette | 1.91% |
| Ratio dettes/capitaux propres | 22.6% |
Quelles ont été les performances à long terme de DD?
Voir les performances historiques et les comparaisonsDividendes
1.7%
Rendement actuel des dividendes384%
Ratio de distributionLe site DD verse-t-il des dividendes fiables ?
Voir DD l'historique des dividendes et les indices de référence| DuPont de Nemours dates des dividendes | |
|---|---|
| Date ex-dividende | May 15 2026 |
| Date de paiement du dividende | May 29 2026 |
| Jours jusqu'au dividende Ex | 7 days |
| Jours jusqu'à la date de paiement du dividende | 7 days |
Le site DD verse-t-il des dividendes fiables ?
Voir DD l'historique des dividendes et les indices de référenceAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/21 23:03 |
| Cours de l'action en fin de journée | 2026/05/21 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
DuPont de Nemours, Inc. est couverte par 38 analystes. 14 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| William Selesky | Argus Research Company |
| Patrick Duffy Fischer | Barclays |
| Michael Leithead | Barclays |